approve!

Emergency attachment of the State Drug Administration approved the domestic new crown pneumonia treatment drug registration application for the State Drug Administration on the 25th in accordance with the special approval procedure of the drug on the 25th. Application.

This drug is the treatment of oral small molecular virus pneumonia for oral small molecular virus pneumonia. On July 20, 2021, the State Drug Administration has attached conditions to approve adult HIV-1 infection patients with the treatment of high virus loads with other reverse-translitease inhibitors. This is an attachment to approve new indications for the treatment of adult patients in ordinary new coronary virus pneumonia. Patients should be used strictly under the guidance of the doctor.

The State Drug Administration requires listing permit holders to continue to carry out relevant research work, complete the requirements for qualified conditions within a time limit, and submit subsequent research results in a timely manner.

Site screenshot

(Source: Website of the State Drug Administration, Xinhua News Agency)

Edit: Hu Rong Hu Kaiyu

- END -